Allergy, Volume 80, Issue 11, Page 3217-3221, November 2025.
Yannick Chantran +17 more
wiley +1 more source
Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasms [PDF]
Myeloproliferative neoplasms (MPN) are a diverse group of chronic hematological disorders that involve unregulated clonal proliferation of white blood cells.
Kapur, Reuben, Pandey, Ruchi
core +1 more source
Familial recurrence of SOX2 anophthalmia syndrome:phenotypically normal mother with two affected daughters [PDF]
The SOX2 anophthalmia syndrome is emerging as a clinically recognizable disorder that has been identified in 10–15% of individuals with bilateral anophthalmia. Extra-ocular anomalies are common.
Bardakjian, Tanya M +11 more
core +1 more source
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis [PDF]
Tiago Azenha Rama +2 more
openalex +1 more source
Human Mast Cells and Mastocytosis: Harnessing MicroRNA Expression as a New Approach to Therapy? [PDF]
MicroRNAs (miRNAs) are short, non-coding RNAs that have emerged as key post-transcriptional regulators in a wide variety of organisms and critical cellular processes.
Deho', Lorenzo, Monticelli, Silvia
core
Dermoscopy in general dermatology: A practical overview [PDF]
Over the last few years, dermoscopy has been shown to be a useful tool in assisting the noninvasive diagnosis of various general dermatological disorders.
Errichetti, Enzo, Stinco, Giuseppe
core +1 more source
Diffuse Cutaneous Mastocytosis with Generalized Bullae [PDF]
Eui Hyung Lee +3 more
openalex +1 more source
Allergy, Volume 80, Issue 10, Page 2904-2908, October 2025.
Jasper B. J. Kamphuis +19 more
wiley +1 more source
Acquired cutis laxa associated with cutaneous mastocytosis [PDF]
Minh Van Hoang +6 more
openalex +1 more source
Erhöhte basale Serumtryptasekonzentration oder Mastozytose als Risikofaktor der Hymenopterengiftallergie Leitlinie der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI) (AWMF-Leitlinie 061/018) [PDF]
Hymenopterengift-allergische Patienten mit Mastzellerkrankung, das heißt Mastozytose und/oder erhöhtem basalen Serumtryptasespiegel, haben ein hohes Risiko schwerer, lebensbedrohender Stichreaktionen.
Jarisch, Reinhart +3 more
core

